According to Ascendis Pharma 's latest financial reports the company's current earnings are C$0.38 Billion. , an increase over its 2023 earnings that were of -C$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | -C$0.4 Billion | -39.35% |
2023 | -C$0.66 Billion | -13.71% |
2022 | -C$0.76 Billion | 23.24% |
2021 | -C$0.62 Billion | -10.38% |
2020 | -C$0.69 Billion | 104.42% |
2019 | -C$0.34 Billion | 61.16% |
2018 | -C$0.21 Billion | 1.07% |
2017 | -C$0.21 Billion | 89.75% |
2016 | -C$0.11 Billion | 103.16% |
2015 | -C$53.51 Million | 186.25% |
2014 | -C$18.7 Million |